Rever
Frontline Intelligence Platform: Human Ingenuity, Augmented by AI
Est 2015|Valuation $20.9M|Raised $10.9M
Published Oct 10, 2026
Public adoption metrics are limited. Third-party databases cite enterprise customers (e.g., Thermo Fisher Scientific, Grupo Bimbo, GlaxoSmithKline, Hyundai, Bridgestone, BASF, Mars, Mitsubishi Heavy Industries) but these claims are typically vendor- or database-reported and should be validated via references.
| Starting Price | Published per-seat pricing referenced on third-party comparison pages (verify with vendor) | Published per-interface pricing with minimum interface commitments (verify with vendor) | Free tier available; published per-seat pricing tiers available from the vendor |
| Best For | Continuous improvement, Kaizen/Lean workflows, frontline idea-to-execution | Building connected-worker apps + integrating devices/systems; composable operations apps | Inspections, audits, issues/actions, operational checklists, broad adoption |
| Key Strength | Structured continuous improvement workflows and frontline engagement; dashboards; manufacturing focus | No-code app building + connectors + device/edge options | Fast rollout for inspections + mature templates/reporting + broad integrations |
| Key Weakness | Public information gaps (security scope, data residency, full pricing); possible support responsiveness concerns | Can require more solution engineering; interface-based pricing model may be unintuitive | Per-seat costs can escalate at scale; some teams want more bespoke workflows than an inspection-first model |
—